Pharma-Bio Serv (PBSV) Capital Expenditures Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -1.25% |
| Oct 31, 2025 | -43.94% |
| Jul 31, 2025 | -27.92% |
| Apr 30, 2025 | -31.16% |
| Oct 31, 2024 | 76.63% |
| Jul 31, 2024 | -27.31% |
| Jan 31, 2024 | -23.27% |
| Oct 31, 2023 | -15.15% |
| Apr 30, 2023 | -35.13% |
| Jan 31, 2023 | -30.88% |
| Oct 31, 2022 | 15.32% |
| Jul 31, 2022 | -44.75% |
| Apr 30, 2022 | -36.83% |
| Jan 31, 2022 | -69.98% |
| Oct 31, 2021 | -14.88% |
| Apr 30, 2021 | -60.29% |
| Jan 31, 2021 | -63.82% |
| Oct 31, 2020 | -51.68% |
| Jul 31, 2020 | -20.57% |
| Apr 30, 2020 | -3.98% |
| Jan 31, 2020 | -20.40% |
| Jul 31, 2019 | -38.42% |
| Apr 30, 2019 | -11.43% |
| Oct 31, 2018 | 7.87% |
| Apr 30, 2018 | -18.31% |
| Jan 31, 2018 | -8.90% |
| Oct 31, 2017 | -63.70% |
| Jul 31, 2017 | -7.53% |
| Apr 30, 2017 | -13.37% |
| Jan 31, 2017 | 109.47% |
| Oct 31, 2016 | 67.52% |
| Jul 31, 2016 | 183.23% |
| Apr 30, 2016 | 29.87% |
| Jan 31, 2016 | 110.34% |
| Oct 31, 2015 | 68.24% |
| Jul 31, 2015 | 34.35% |